300
Participants
Start Date
November 30, 2008
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Immune Globulin Intravenous (IVIG)
A single dose of intravenous immune globulin or saline placebo administered within 24 hours of hospital presentation. The maximum dose in Phase I was 800 mg/kg. The dose for Phase II is 400mg/kg.
Normal saline
A single dose of normal saline administered within 24 hours of hospital admission for uncomplicated pain crisis.
RECRUITING
Montefiore Medical Center, The Bronx
Collaborators (1)
Food and Drug Administration (FDA)
FED
Case Western Reserve University
OTHER
Grifols Therapeutics LLC
INDUSTRY
Deepa Manwani
OTHER